DRREDDY.BO

Dr. Reddy's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,271.75

Jun 10, 2026

AI Brief

Market cap

$1.06T

52w range

—

P / E

—

EPS · FY 2026

$51.42

Volume

—

Revenue · FY 2026

$335.93B

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on Dr. Reddy's Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1271.75

Change

+7.52%

Period high

$1336.95

Period low

$1182.35

Period start

$1182.752026-02-01

Through 2026-06-10

Fair value

Football field →

Weighted blend

$1,116.74

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Communication Services
+1.27%
Consumer Defensive
+0.71%
Energy
+0.36%
Financial Services
-0.01%
Real Estate
-0.10%
Healthcare
-0.64%
Technology
-0.75%
Consumer Cyclical
-1.09%
Basic Materials
-1.81%
Utilities
-2.31%
Industrials
-3.22%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-1.31%
Engineering & Construction
-5.41%
Independent Power Producers
-4.65%
Agricultural - Machinery
-4.52%
Construction
-4.41%
Auto - Recreational Vehicles
-4.03%
Department Stores
-3.97%
Industrial - Machinery
-3.93%
Construction Materials
-3.39%
Renewable Utilities
-3.37%
Auto - Parts
-3.34%
Rental & Leasing Services
-3.23%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DRREDDY.BO.

Peers

No peer list available for DRREDDY.BO.

Total assets

$579.35B

Total debt

$77.34B

Cash & equiv

$15.37B

Operating CF

$53.84B

Free cash flow

$30.51B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$335.93B	$46.44B	$42.85B	$51.42	+12.76%